Silvant Capital Management LLC Penumbra Inc Transaction History

Silvant Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$238.08 - $288.0 $16,189 - $19,584	-68 Reduced 5.96%	1,072 $308,000
Q2 2021 Aug 03, 2021	SELL	$235.0 - $310.7 $82,485 - $109,055	-351 Reduced 23.54%	1,140 $312,000
Q4 2020 Feb 05, 2021	SELL	$174.98 - $272.83 $221,699 - $345,675	-1,267 Reduced 45.94%	1,491 $261,000
Q1 2018 May 09, 2018	BUY	$84.6 - $126.1 $233,326 - $347,783	2,758 New	2,758 $319,000

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.09B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Silvant Capital Management LLC with notifications on news.